Behavioral/neuropsychological outcomes and quality of life endpoints

Frontiers of Neurology and Neuroscience

Volumn 25, Issue , 2009, Pages 78-92

  Levin, Bonnie E ^a  

^a UNIVERSITY OF MIAMI   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ILLICIT DRUG;

ALCOHOL CONSUMPTION; ALERTNESS; APHASIA; APTITUDE TEST; ATTENTION; AUTOANALYSIS; AUTOMATION; BEHAVIOR; CLINICAL PROTOCOL; CLINICAL RESEARCH; COGNITION; COGNITIVE DEFECT; COMPUTER ANALYSIS; DEMOGRAPHY; DEPRESSION; DEPTH PERCEPTION; DIAGNOSTIC ACCURACY; DRUG USE; EMOTIONALITY; ETHNIC GROUP; EYE TRACKING; FATIGUE; GROUP DYNAMICS; GROUPS BY AGE; HEALTH CARE; HEALTH STATUS; HUMAN; INTELLECT; INTELLIGENCE; LANGUAGE; LANGUAGE ABILITY; LANGUAGE TEST; LEARNING; MEMORY; MENTAL HEALTH; MOOD DISORDER; MOTOR PERFORMANCE; NEUROPSYCHOLOGICAL TEST; NEUROPSYCHOLOGY; OSCILLATION; OUTCOME ASSESSMENT; PHARMACODYNAMICS; PLANNING; PRESCRIPTION; PRIORITY JOURNAL; PSYCHOMETRY; PSYCHOMOTOR PERFORMANCE; QUALITY OF LIFE; RESEARCH SUBJECT; REVIEW; SCORING SYSTEM; SELF MONITORING; SENSITIVITY AND SPECIFICITY; SKILL; STANDARD; VISUAL DISCRIMINATION; VISUAL MEMORY; VISUAL ORIENTATION; VISUOMOTOR COORDINATION; WORKING MEMORY; ARTICLE; CLINICAL TRIAL; DRUG EFFECT; MENTAL FUNCTION; METHODOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGICAL ASPECT; PSYCHOMOTOR DISORDER; STATISTICS; TREATMENT OUTCOME;

ATTENTION; BEHAVIOR; CLINICAL TRIALS AS TOPIC; HUMANS; LANGUAGE; MENTAL PROCESSES; NEUROPSYCHOLOGICAL TESTS; PSYCHOMOTOR DISORDERS; QUALITY OF LIFE; RESEARCH DESIGN; TREATMENT OUTCOME;

EID: 67649756385     PISSN: 16604431     EISSN: 16622804     Source Type: Book Series    
DOI: 10.1159/000209480     Document Type: Review

References (70)

1. Levin B: Clinical trial reviewer criteria. NINDS workshop measuring cognitive functioning outcomes in neurology research. Washington, D.C., 2004.
2. Hachinski V, Iadecola C, Petersen RC, Breteler MM, Nyenhuis DL, Black SE, Powers WJ, DeCarli C, Merino JG, Kalaria RN, Vinters HV, Holtzman DM, Rosenberg GA, Wallin A, Dichgans M, Marler JR, Leblanc GG: National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive impairment harmonization standards. Stroke 2006;37:2220-2241.
3. Vardy J, Rourke S, Tannock IF: Evaluation of cognitive function associated with chemotherapy: a review of published studies and recommendations for future research. J Clin Oncol 2007;25:2455-2463.
4. Spreen O, Sherman EMS, Strauss E: A Compendium of Neuropsychological Tests: Administration, Norms, and Commentary. New York, Oxford University Press, 2006.
5. Demers L, Oremus M, Perrault A, Champoux N, Wolfson C. Review of outcome measurement instruments in Alzheimer's disease drug trials: Psychometric properties of functional and quality of life scales. J Geriatr Psychiatry Neurol 2000;13: 170-180.
6. Kilada S, Gamaldo A, Grant EA, Moghekar A, Morris JC, O'Brien RJ: Brief screening tests for the diagnosis of dementia: comparison with the mini-mental state exam. Alzheimer Dis Assoc Disord 2005;19:8-16.
7. Brodaty H, Low LF, Gibson L, Burns K: What is the best dementia screening instrument for general practitioners to use? Am J Geriatr Psychiatry 2006; 14:391-400.
8. Gifford DR, Cummings JL: Evaluating dementia screening tests: Methodologic standards to rate their performance. Neurology 199915;52:224-227.
9. Woodford HJ, George J: Cognitive assessment in the elderly: a review of clinical methods. QJM 2007; 100:469-484.
10. Cullen B, O'Neill B, Evans JJ, Coen RF, Lawlor BA: A review of screening tests for cognitive impairment. J Neurol Neurosurg Psychiatry 2007;78:790-799.
11. Lorentz WJ, Scanlan JM, Borson S: Brief screening tests for dementia. Can J Psychiatry 2002;47:723-733.
12. Lezak MD: Neuropsychological Assessment. New York, Oxford University Press, 1995.
13. Heaton RK, Grant I, Matthews CG: Comprehensive Norms for an Expanded Halstead-Reitan Battery: Demographic Corrections, Research Findings, and Clinical Applications. Odessa, Psychological Assessment Resources, 1991.
14. Attix DK, Welsh-Bohmer KA: Geriatric Neuro-psychology: Assessment and Intervention. New York, The Guilford Press, 2005.
15. Dikmen SS, Heaton RK, Grant I, Temkin NR: Test-retest reliability and practice effects of expanded halstead-reitan neuropsychological test battery. J Int Neuropsychol Soc 1999;5:346-356.
16. Cronbach LJ, Meehl PE: Construct validity in psychological tests. Psychol Bull 1955;52:281-302.
17. Smith GT: On construct validity: issues of method and measurement. Psychol Assess 2005;17:396-408.
18. Rabin LA, Barr WB, Burton LA: Assessment practices of clinical neuropsychologists in the United States and Canada: a survey of INS, NAN, and APA division 40 members. Arch Clin Neuropsychol 2005;20:33-65.
19. The Psychological Corporation: WAIS-III/WMS-III: Updated Technical Manual. San Antonio, The Psychological Corporation, 2002.
20. Delis DC, Kramer JH, Kaplan E, Ober BA: California Verbal Learning Test, ed 2. San Antonio, The Psychological Corporation, 2000.
21. Caplan D: Aphasic syndromes; in Heilman KM, Valenstein E (eds): Clinical Neuropsychology, ed 4. New York, Oxford University Press, 2003.
22. Levin BE: Spatial confusion in Parkinson's disease. Alzheimer Dis Relat Disord 1990;4:161-170.
23. Levin BE: Visuospatial decline in Parkinson's disease. Neurology 1991;41:365-369.
24. Meyers J, Meyers K: Rey Complex Figure and the Recognition Trial: Professional Manual. Supplemental Norms for Children and Adolescents. Odessa, Psychological Assessment Resources, 1996.
25. Reitan RM, Wolfson D: The Halstead-Reitan Neuropsychological Test Battery. Tucson, Neuropsychology Press, 1985.
26. Bauer RM, Grande L, Valenstein E: Amnesic disorders; in Heilman KM, Valenstein E (eds): Clinical Neuropsychology, ed 4. New York, Oxford University Press, 2003.
27. Eichenbaum H: Learning and Memory. New York, Norton & Co., 2008.
28. Denckla MB: A theory and model of executive function: a neuropsychological perspective; in Lyon GR, Krasnegor NA (eds): Attention, Memory and Executive Function. Baltimore, Brookes, 1996.
29. Rabbitt P (ed): Methodology of Frontal and Executive Function. Hove, Psychology Press, 1997.
30. Heaton RK, Ryan L, Grant I, Matthews CG: Demographic influences on neuropsychological test performance; in Igor G, Adams G (eds): Neuropsychological Assessment of Neuropsychia-tric Disorders, ed 2. New York, Oxford University Press, 1996.
31. Mitrushina MN, Boone KL, D'Elia L: Handbook of Normative Data for Neuropsychological Assessment. New York, Oxford University Press, 2005.
32. Bornstein RA: Normative data on selected neuro-psychological measures from a nonclinical sample. J Clin Psychol 1985;41:651-659.
33. Meyers AR, Gage H, Hendricks A: Health-related quality of life in neurology. Arch Neurol 2000;57: 1224-1227.
34. Haywood KL, Garratt AM, Fitzpatrick R: Quality of life in older people: a structured review of generic self-assessed health instruments. Qual Life Res 2005;14:1651-1668.
35. Wiebe S, Guyatt G, Weaver B, Matijevic S, Sidwell C: Comparative responsiveness of generic and specific quality-of-life instruments. J Clin Epidemiol 2003;56:52-60.
36. Bergner M, Bobbitt RA, Carter WB, Gilson BS: The sickness impact profile: Development and final revision of a health status measure. Med Care 1981;19: 787-805.
37. Ware JE, Snow KK, Kosinski M, Gandek B: SF-36 Health Survey Manual and Interpretation guide. Boston, New England Medical Center, The Health Institute, 1993.
38. Murrell R: Quality of life and neurological illness: a review of the literature. Neuropsychol Rev 1999;9: 209-229.
39. Wilson SL, McMillan TM: Computer-based assessment in neuropsychology; in Crawford JR, Parker DM, McKinlay DM (eds): A Handbook of Neuropsychological Assessment. East Sussex, Psychology Press, Taylor & Francis Group, 1992.
40. Broglio SP, Ferrara MS, Macciocchi SN, Baumgartner TA, Elliott R: Test-retest reliability of computerized concussion assessment programs. J Athl Train 2007; 42:509-514.
41. Schatz P, Browndyke J: Applications of computer-based neuropsychological assessment. J Head Trauma Rehabil 2002;17:395-410.
42. United States Census 2000. Washington DC, US Census Bureau, 2000. http://www.census.gov/main/ www/cen2000.html.
43. Manly JJ, Echemendia RJ: Race-specific norms: using the model of hypertension to understand issues of race, culture, and education in neuropsy-chology. Arch Clin Neuropsychol 2007;22:319-325.
44. Artiola I, Fortuny L, Garolera M, Hermosillo Romo D, Feldman E, Fernandez Barillas H, Keefe R, Lemaitre MJ, Ortiz Martin A, Mirsky A, Monguio I, Morote G, Parchment S, Parchment LJ, Da Pena E, Politis DG, Sedo MA, Taussik I, Valdivia F, De Valdivia LE, Verger Maestre K: Research with Spanish-speaking populations in the United States: lost in the translation. A commentary and a plea. J Clin Exp Neuropsychol 2005;27:555-564.
45. Wolfe N: Cross-cultural neuropsychology of aging and dementia; in Ferraro FR (ed): Minority and Cross-Cultural Aspects of Neuropsychological Assessment. Exton, Swets & Zeitlinger, 2002.
46. Harris JG, Tulsky DS, Schultheis MT: Assessment of the Non-Native English Speaker: Assimilating History and Research Findings to Guide Practice. Clinical Interpretation of the WAIS-III and WMS-III. San Diego, Elsevier Science, 2003.
47. Manly JJ: Advantages and disadvantages of separate norms for african americans. Clin Neuropsychol 2005;19:270-275.
48. Boone KB, Victor TL, Wen J, Razani J, Ponton M: The association between neuropsychological scores and ethnicity, language, and acculturation variables in a large patient population. Arch Clin Neuro-psychol 2007;22:355-365.
49. Shipley WP: Shipley-Institute of Living Scale for Measuring Intellectual Impairment: Manual for Directions and Scoring. Hartford, Institute of Living, 1939.
50. Nelson HE: National Adult Reading Test (NART); Test Manual. Windsor, NFER Nelson, 1982.
51. Nelson HE, Willison J: National Adult Reading Test (NART): Test Manual, ed 2. Windsor, NFER Nelson, 1991.
52. Blair JR, Spreen O: Predicting premorbid IQ: a revision of the national adult reading test. Clin Neuropsychol 1989;3:129.
53. Beardsall L, Brayne C: Estimation of verbal intelligence in an elderly community: a prediction analysis using a shortened NART. Br J Clin Psychol 1990; 29:83-90.
54. Powell J: The effects of medication and other substances on cognitive functioning; in Goldstein LH, McNeil JE (eds): Clinical Neuropsychology: A Practical Guide to Assessment and Management for Clinicians. Hoboken, John Wiley & Sons, 2004.
55. Turnheim K: When drug therapy gets old: pharma-cokinetics and pharmacodynamics in the elderly. Exp Gerontol 2003;38:843-853.
56. Beavis J, Kerr M, Marson AG: Pharmacological interventions for epilepsy in people with intellectual disabilities. Cochrane Database Syst Rev 2007;3: CD005399.
57. Lippe S, Lassonde M: Neuropsychological profile of intractable partial epilepsies. Rev Neurol (Paris) 2004;160:5S144-5S153.
58. Loring DW, Marino S, Meador KJ: Neuropsy-chological and behavioral effects of antiepilepsy drugs. Neuropsychol Rev 2007;17:413-425.
59. Schubert R: Attention deficit disorder and epilepsy. Pediatr Neurol 2005;32:1-10.
60. Green J: Neuropsychological Evaluation of the Older Adult: A Clinician's Guidebook. San Diego, Academic Press, 2000.
61. Lundqvist T: Cognitive consequences of cannabis use: Comparison with abuse of stimulants and heroin with regard to attention, memory and executive functions. Pharmacol Biochem Behav 2005;81:319-330.
62. Coulston CM, Perdices M, Tennant CC: The neuro-psychological correlates of cannabis use in schizophrenia: lifetime abuse/dependence, frequency of use, and recency of use. Schizophr Res 2007;96:169-184.
63. Harper C, Matsumoto I: Ethanol and brain damage. Curr Opin Pharmacol 2005;5:73-78.
64. Kalechstein AD, De La Garza R 2nd, Mahoney JJ 3rd, Fantegrossi WE, Newton TF: MDMA use and neurocognition: a meta-analytic review. Psycho-pharmacology (Berl) 2007;189:531-537.
65. Corbie-Smith G, Viscoli CM, Kernan WN, Brass LM, Sarrel P, Horwitz RI: Influence of race, clinical, and other socio-demographic features on trial participation. J Clin Epidemiol 2003;56:304-309.
66. Levin BE, Katzen HL, Klein B, Llabre ML: Cognitive decline affects subject attrition in longitudinal research. J Clin Exp Neuropsychol 2000;22:580-586.
67. Marcopulos B, McLain C: Are our norms 'normal'? A 4-year follow-up study of a biracial sample of rural elders with low education. Clin Neuropsychol 2003;17:19-33.
68. Manley JJ: Advantages and disadvantages of separate norms for African Americans. Clin Neuropsychol 2005;19:270-275.
69. Loftin WA, Barnett SK, Bunn PS, Sullivan P: Recruitment and retention of rural African Americans in diabetes research: lessions learned. Diabetes Educ 2005;31:251-259.
70. Carroll KM: Enhancing retention in clinical trials of psychosocial treatments: practical strategies. NIDA Res Monogr 1997;165:4-24.